On February 11 the U.S. FDA reportedly approved the first mammography device that gives 3-dimensional images of the breast for cancer screening and diagnosis.
The unique and innovative new system is significantly more accurate and provides both 2- and 3-D x-ray images of the breast. Because of difficult screening, the previously conventional 2-dimensional system recommended that 10% of the patients undergo additional testing.
While the dose of radiation will double, it will improve the accuracy by at least 7% with which radiologists will detect breast cancer.
There is a 98% survival rate when breast cancer is detected early and still localized.